Dutch Supermarkets Plan OTC Sales Boost

7 April 1996

Dutch supermarket chains plan to increase sales of over-the-counter drugs, but are divided as to whether pharmacies will have to be added to the stores, says a survey carried out by the Distrifood trade journal. Strict rules on opening of pharmacies have now been relaxed, but the law still prohibits combination supermarket/pharmacies, although this could be circumvented by creating a separate entry to the pharmacy, adjacent to the supermarket.

Leading chain Albert Heijn forecasts that at least 200 of its stores will be selling OTCs this year, and estimates that its prices will be 10%-15% cheaper than those charged by pharmacies, noting that the gross margins on OTC products are in the region of 32%-37%. There is concern that the large supermarkets will use these margins as a means of attracting customers; the Konmar chain is already selling a variety of OTCs at cheaper prices.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight